In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants

AIDS

Volumn 28, Issue 10, 2014, Pages 1421-1430

  Kidzeru, Elvis B ^a   Hesseling, Anneke C ^b   Passmore, Jo Ann S ^a,c   Myer, Landon ^a   Gamieldien, Hoyam ^a   Tchakoute, Christophe Toukam ^a   Gray, Clive M ^a,c   Sodora, Donald L ^d   Jaspan, Heather B ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; Infants; Maternal HIV; Proliferation; T cell immunity; Vaccination

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; ORAL POLIOMYELITIS VACCINE; STAPHYLOCOCCUS ENTEROTOXIN B; ACELLULAR VACCINE; CYTOKINE; KI 67 ANTIGEN; PERTUSSIS VACCINE; STAPHYLOCOCCUS VACCINE;

ARTICLE; BIRTH WEIGHT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; FEEDING; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; LYMPHOCYTE PROLIFERATION; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUBERCULOSIS; VACCINATION; AFRICA SOUTH OF THE SAHARA; BIOSYNTHESIS; COHORT ANALYSIS; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; LONGITUDINAL STUDY; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION;

AFRICA SOUTH OF THE SAHARA; BCG VACCINE; CELL PROLIFERATION; COHORT STUDIES; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; KI-67 ANTIGEN; LONGITUDINAL STUDIES; MALE; MATERNAL-FETAL EXCHANGE; PERTUSSIS VACCINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STAPHYLOCOCCAL VACCINES; T-LYMPHOCYTES; VACCINES, ACELLULAR;

EID: 84902254078     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000292     Document Type: Article

References (53)

1. The Henry J. US global health policy fact: the global HIV/AIDS Epidemic.Kaiser Family Foundation/UNAIDS; 2012, 3030-17, 1-2.
2. Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, et al. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 2012; 366:2368-2379.
3. Afran L, Garciaknight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system Clin Exp Immunol 2014; 176:11-22.
4. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010; 126:e631-e638.
5. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA. Infectious disease morbidity among young HIV-1: exposed but uninfected infants in Latin American and Caribbean countries. Pediatrics 2006; 462:e694-e704.
6. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K. Morbidity among human immunodeficiency virus-exposed but immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
7. Kuhn L, Kasonde P, Sinkala M, Kankasa C, Scott N, Tsai W, et al. Does severity of HIV disease in hiv-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2006; 41:1654-1661.
8. Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-526.
9. Legrand Fatema A, Nixons D, Loo CP, Ono E, Chapman JM, Miyamoto M, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PloS One 2006; e102:1-10.
10. Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis 2002; 34:267-276.
11. Buseyne F, Blanche S, Rivipre Y. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J Immunol 1993; 150:3569-3581.
12. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
13. Jaspan HB, Hanekom WA. Immunology of infants through adolescents: responses to emulate for HIV vaccines. Curr Opin HIV AIDS 2007; 2:391-398.
14. Lambert P-H, Liu M, Siegrist C-A. Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med 2005; 11:S54-62.
15. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009; 183:7150-7160.
16. Marchant A, Goetghebuer T, Ota MO, Ceesay SJ, De Groote D, Corrah T, et al. Newborns develop a Th1-type immune response to mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol 1999; 163:2249-2255.
17. Fiorilli M, Sirianni MC, Iannetti P, Pana A, Divizia M, Aiuti F. Cell-mediated immunity in human cytomegalovirus infection. Infect Immun 1982; 35:1162-1164.
18. Vakkila J, AystöS, Saarinen-Pihkala UM, Sariola H. Naive CD4R T cells can be sensitized with IL-7. Scand J Immunol 2001; 54:501-505.
19. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996; 26:659-668.
20. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 2005; 102:2880-2885.
21. Schulz EG, Mariani L, Radbruch A, Höfer T. Sequential polarization andimprinting of type 1 T helper lymphocytes by interferongamma and interleukin-12. Immunity 2009; 30:673-683.
22. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. Th1 and Th2 cytokine production by peripheralblood mononuclear-cells from HIV-infected patients. AIDS 1994; 8:757-762.
23. Williams A, Steffens F, Reinecke C, Meyer D. The Th1/Th2/ Th17 cytokine profile of HIV-infected individuals: a multivariate cytokinomics approach. Cytokine 2013; 61:521-526.
24. Gulzar N, Diker B, Balasubramanian S, Jiang JQ, Copeland KFT. Human immunodeficiency virus-1 infection protects against a Tc1-to-Tc2 shift in CD8(R) T cells. Hum Immunol 2011; 72:995-1000.
25. Borges-Almeida E, Milanez HM, Vilela MMS, Cunha FGP, Abramczuk BM, Reis-Alves SC, et al. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed noninfected newborns.BMC Infect Dis 2011; 38:1-11.
26. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305:576-584.
27. City of Cape Town. HIV, AIDS and TB PLAN 2010/2011.
28. 1-4 28. South African Department of Health. Clinical guidelines: PMTCT (prevention of mother-to-child transmission). National Department of Health, South Africa: South African National AIDS Council; 2010.
29. WHO-SA.G.E. Weekly epidemiological record (Relevé épidé- miologique hebdomadaire). 2007. pp. 181-196.
30. Department of Health. SA child immunisation. 2009.
31. Soares A, Govender L, Hughes J, Mavakla W, De Kock M, Barnard C, et al. Novel application of Ki67 to quantify antigenspecific in vitro lymphoproliferation. J Immunol Methods 2010; 362:43-50.
32. Rueggs CL, Rajasekar S, Stein S, Engleman EG. Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. J Biol Chem 1992; 267:18837-18849.
33. Columb MO, Sagadai S. Multiple comparisons. Curr Anaesth Crit Care 2006; 17:233-236.
34. Hygino J, Lima PG, Filho RGS, Silva AAL, Saramago CSM, Andrade RM, et al. Altered immunological reactivity in HIV- 1-exposed uninfected neonates. Clin Immunol 2008; 127:340-347.
35. Beveridge NER, Price DA, Casazza JP, Pathan AA, Clare R, Asher TE, et al. Immunisation with BCG and recombinant MVA85A induces longlasting, polyfunctional Mycobacterium tuberculosis-specific CD4R memory T lymphocyte populations. Eur J Immunol 2008; 37:3089-3100.
36. Makedonas G, Betts MR. Polyfunctional analysis of human T cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 2006; 28:209-219.
37. Darrah PA, Patel DT, De Luca PM, Lindsay RWB, Davey DF, Flynn BJ, et al. Multifunctional T H 1 cells define a correlate of vaccine- mediated protection against Leishmania major. Nat Med 2007; 13:843-850.
38. Mansoor N, Scriba TJ, De Kock M, Tameris M, Keyser A, Little F, et al. Infant HIV-1 infection severely impairs the bacille Calmette-Guerin vaccine-induced immune response. J Infect Dis 2010; 199:1-17.
39. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-2254.
40. Wozniak TM, Saunders BM, Ryan AA, Britton WJ. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 2010; 78:4187-4194.
41. De Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PWM, Mooi FR. Pertussis: a matter of immune modulation. FEMS Microbiol Rev 2011; 35:441-474.
42. Mills KH, Barnard A, Watkins J, Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993; 61:399-410.
43. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. Vaccineand antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997; 65:2168-2174.
44. Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013; 9:e1003264.
45. Mills KHG, Th T. Immunity to Bordetella pertussis. Microbes Infect 2001; 3:655-677.
46. Miles DJC, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology 2010; 129:446-454.
47. Mazzola N, Marcos TN, Abramczuk BM. Impaired bacillus Calmette: Gue response in HIV-exposed, uninfected infants. AIDS 2011; 25:2079-2087.
48. Kou ZC, Puhr JS, Rojas M, Wayne T, Goodenow MM, Sleasman JW, et al. T-Cell receptor V ( repertoire CDR3 length diversity differs within CD45RA and CD45RO T-cell subsets in healthy and human immunodeficiency virus. Clin Diagn Lab Immunol 2000; 7:953-959.
49. Halapi E, Andersson R, Rossi P, Wigzell H, Grunewald J. Diverse T-cell receptor CDR3 length patterns in human CD4 and CD8 T lymphocytes from newborns and adults. Scand J Immunol 1999; 49:149-154.
50. Rich KC, Siegel JN, Jennings C, Rydman RJ. Function and phenotype of immature CD4R lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency. Virus Infect Mothers 1997; 4:358-361.
51. Miyamoto M, Pessoa SD, Ono E, Machado DM, Salomao R, Succi RCDM, et al. Low CD4R T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Pediatr 2010; 56:427-432.
52. Wongnoi R, Penvieng N, Singboottra P, Kingkeow D, Oberdorfer P, Sirivatanapa P. Hematological alterations and thymic function in newborns of HIV-infected mothers receiving antiretroviral drugs. Indian Pediatr 2013; 50:567-572.
53. Shah I. Immunological and hematological effects of perinatal exposure to antiretroviral drugs in HIV exposed, non infected children. Indian Pediatr 2013; 50:565-566.